Bioglan Pharma
Article Abstract:
Bioglan Pharma is a specialist pharmaceutical company that should benefit from its acquisition of Hexal's skincare division.
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
Fulcrum Pharma
Article Abstract:
The performance of Fulcrum Pharma is examined, and the company's strengths include a strong Japanese presence.
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
SR Pharma
Article Abstract:
SR Pharma has an increasing number of licensing agreements, though the company's cash pile is limited.
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Cantab Pharmaceuticals. Merck and Co
- Abstracts: A wooly area. Roche. KS Biomedix
- Abstracts: The way ahead. Volume control. Stop, look, listen
- Abstracts: Domestic bond markets. Clearing the paper trail. The year of Asian domestic bonds
- Abstracts: Drugs in crops-the unpalatable truth. China pushes liver proteomics. Pharmacogenetics and the practice of medicine